Skip to main navigation Skip to search Skip to main content

Rapid emergence of effect of atorvastatin on cardiovascular outcomes in the Collaborative Atorvastatin Diabetes Study (CARDS)

  • H M Colhoun
  • , D J Betteridge
  • , P N Durrington
  • , G A Hitman
  • , H A W Neil
  • , S J Livingstone
  • , M J Thomason
  • , J H Fuller

    Research output: Contribution to journalArticlepeer-review

    Abstract

    The aim of this study was to determine the pattern of the effect of the 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor atorvastatin on cardiovascular events in patients with type 2 diabetes and no prior history of cardiovascular disease (CVD).
    Original languageEnglish
    Pages (from-to)2482-2485
    Number of pages4
    JournalDiabetologia
    Volume48
    Issue number12
    DOIs
    Publication statusPublished - 2005

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Fingerprint

    Dive into the research topics of 'Rapid emergence of effect of atorvastatin on cardiovascular outcomes in the Collaborative Atorvastatin Diabetes Study (CARDS)'. Together they form a unique fingerprint.

    Cite this